Position in HLN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$344,846
-$664,083 QoQ
Shares Held
36,961
-61.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#225
of 639 holders
Holding Since
Sep 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Advisors Preferred, LLC holds $5,582,057 across 2 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
31,074 | $5,237,211 | |
| 2 | HLN |
Haleon plc
This page
|
36,961 | $344,846 |
All Filings in HLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $344,846 | 36,961 | Shares | Other | 2026-08-11 | |
| 2024-09-30 | $1,008,929 | 95,362 | Shares | Other | 2024-10-15 | |
| No filing history on record for this holder in this stock. | ||||||